USANA Health Sciences, Inc. (USNA) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
USANA Health Sciences, Inc. (USNA) Bundle
Looking to assess the intrinsic value of USANA Health Sciences, Inc.? Our USNA DCF Calculator integrates real-world data with comprehensive customization features, allowing you to refine your forecasts and enhance your investment choices.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,060.9 | 1,134.6 | 1,186.5 | 998.6 | 921.0 | 893.2 | 866.2 | 840.0 | 814.6 | 790.0 |
Revenue Growth, % | 0 | 6.95 | 4.57 | -15.83 | -7.77 | -3.02 | -3.02 | -3.02 | -3.02 | -3.02 |
EBITDA | 146.2 | 201.0 | 192.9 | 130.2 | 123.1 | 132.5 | 128.5 | 124.6 | 120.8 | 117.2 |
EBITDA, % | 13.78 | 17.71 | 16.26 | 13.04 | 13.37 | 14.83 | 14.83 | 14.83 | 14.83 | 14.83 |
Depreciation | 22.8 | 22.5 | 22.2 | 21.4 | 20.4 | 18.5 | 17.9 | 17.4 | 16.9 | 16.4 |
Depreciation, % | 2.15 | 1.98 | 1.87 | 2.14 | 2.21 | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 |
EBIT | 123.4 | 178.5 | 170.7 | 108.8 | 102.7 | 114.0 | 110.5 | 107.2 | 103.9 | 100.8 |
EBIT, % | 11.63 | 15.73 | 14.39 | 10.9 | 11.15 | 12.76 | 12.76 | 12.76 | 12.76 | 12.76 |
Total Cash | 234.8 | 311.9 | 239.8 | 288.4 | 330.4 | 240.4 | 233.2 | 226.1 | 219.3 | 212.7 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 8.8 | 7.4 | 7.2 | 7.2 | 7.2 | 6.4 | 6.2 | 6.0 | 5.8 | 5.7 |
Account Receivables, % | 0.8259 | 0.65395 | 0.60373 | 0.72231 | 0.78186 | 0.71755 | 0.71755 | 0.71755 | 0.71755 | 0.71755 |
Inventories | 68.9 | 90.2 | 98.3 | 67.1 | 61.5 | 64.5 | 62.6 | 60.7 | 58.9 | 57.1 |
Inventories, % | 6.49 | 7.95 | 8.29 | 6.72 | 6.67 | 7.22 | 7.22 | 7.22 | 7.22 | 7.22 |
Accounts Payable | 12.5 | 18.2 | 13.5 | 11.0 | 10.1 | 10.9 | 10.6 | 10.3 | 10.0 | 9.7 |
Accounts Payable, % | 1.18 | 1.6 | 1.14 | 1.11 | 1.09 | 1.22 | 1.22 | 1.22 | 1.22 | 1.22 |
Capital Expenditure | -16.6 | -15.1 | -12.8 | -10.4 | -14.5 | -11.8 | -11.4 | -11.1 | -10.7 | -10.4 |
Capital Expenditure, % | -1.56 | -1.33 | -1.08 | -1.04 | -1.57 | -1.32 | -1.32 | -1.32 | -1.32 | -1.32 |
Tax Rate, % | 37.74 | 37.74 | 37.74 | 37.74 | 37.74 | 37.74 | 37.74 | 37.74 | 37.74 | 37.74 |
EBITAT | 82.4 | 125.0 | 116.5 | 69.5 | 64.0 | 75.5 | 73.2 | 71.0 | 68.9 | 66.8 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | 23.5 | 118.1 | 113.4 | 109.2 | 74.5 | 80.8 | 81.6 | 79.1 | 76.7 | 74.4 |
WACC, % | 8.53 | 8.54 | 8.54 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 |
PV UFCF | ||||||||||
SUM PV UFCF | 310.3 | |||||||||
Long Term Growth Rate, % | 0.50 | |||||||||
Free cash flow (T + 1) | 75 | |||||||||
Terminal Value | 931 | |||||||||
Present Terminal Value | 618 | |||||||||
Enterprise Value | 928 | |||||||||
Net Debt | -317 | |||||||||
Equity Value | 1,245 | |||||||||
Diluted Shares Outstanding, MM | 19 | |||||||||
Equity Value Per Share | 64.38 |
What You Will Get
- Real USNA Financial Data: Pre-filled with USANA’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See USANA’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Financial Data: USANA Health Sciences, Inc.'s historical financial statements and pre-populated projections.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Valuation: Observe USANA's intrinsic value update instantly as you adjust inputs.
- Intuitive Visualizations: Interactive dashboard charts illustrate valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review USANA Health Sciences, Inc.'s pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust assumptions.
- Step 5: Analyze the outputs and leverage the results for investment decisions.
Why Choose This Calculator for USANA Health Sciences, Inc. (USNA)?
- Accuracy: Utilizes real USANA financials for precise data representation.
- Flexibility: Tailored for users to easily adjust and experiment with inputs.
- Time-Saving: Avoid the complexity of constructing a financial model from the ground up.
- Professional-Grade: Crafted with the insight and precision expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users with varying financial expertise.
Who Should Use This Product?
- Investors: Accurately estimate USANA Health Sciences, Inc.'s (USNA) fair value before making investment decisions.
- CFOs: Leverage a professional-grade DCF model for financial reporting and analysis specific to USANA (USNA).
- Consultants: Quickly adapt the template for valuation reports tailored to USANA (USNA) clients.
- Entrepreneurs: Gain insights into financial modeling practices used by leading health and wellness companies like USANA (USNA).
- Educators: Use it as a teaching tool to demonstrate valuation methodologies relevant to the health sciences sector, including USANA (USNA).
What the Template Contains
- Pre-Filled Data: Includes USANA Health Sciences’ historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze USANA’s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.